脑动极光医疗科技香港上市募资5.83亿港元认知障碍数字疗法市场领先

观点网01-09 07:38

观点网讯：1月9日，浙江绍兴的脑动极光医疗科技有限公司（BrainAurora Medical Technology Limited，简称“脑动极光”）（06681.HK）在香港联合交易所主板成功上市。此次IPO全球发售1.81112亿股，占发行后总股份的14.30%，每股定价3.22港元，募集资金总额约5.83亿港元，净额约5.01亿港元。公开发售部分获得11.39倍认购，国际发售部分获得...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2502403830?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-01-09 07:38","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2502403830","market":"hk","top_or_hot":-1,"title":"脑动极光医疗科技香港上市 募资5.83亿港元 认知障碍数字疗法市场领先","media":"观点网","content":"<div>\n<p>观点网讯：1月9日，浙江绍兴的脑动极光医疗科技有限公司（BrainAurora Medical Technology Limited，简称“脑动极光”）（06681.HK）在香港联合交易所主板成功上市。此次IPO全球发售1.81112亿股，占发行后总股份的14.30%，每股定价3.22港元，募集资金总额约5.83亿港元，净额约5.01亿港元。公开发售部分获得11.39倍认购，国际发售部分获得...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010907574795fd57dc&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>脑动极光医疗科技香港上市 募资5.83亿港元 认知障碍数字疗法市场领先</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n脑动极光医疗科技香港上市 募资5.83亿港元 认知障碍数字疗法市场领先\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-09 07:38 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010907574795fd57dc&s=b><strong>观点网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>观点网讯：1月9日，浙江绍兴的脑动极光医疗科技有限公司（BrainAurora Medical Technology Limited，简称“脑动极光”）（06681.HK）在香港联合交易所主板成功上市。此次IPO全球发售1.81112亿股，占发行后总股份的14.30%，每股定价3.22港元，募集资金总额约5.83亿港元，净额约5.01亿港元。公开发售部分获得11.39倍认购，国际发售部分获得...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010907574795fd57dc&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06681","symbol_name":"脑动极光-B","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010907574795fd57dc&s=b","article_id":"2502403830","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010907574795fd57dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2502403830","pubTimestamp":1736379480,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"此次IPO全球发售1.81112亿股，占发行后总股份的14.30%，每股定价3.22港元，募集资金总额约5.83亿港元，净额约5.01亿港元。脑动极光此次IPO引入4名基石投资者，合计认购1.16406亿股，约合4850万美元。脑动极光成立于2012年，是中国认知障碍数字疗法市场的资深参与者，也是中国首家将脑科学与人工智能技术相结合开发医疗级数字疗法产品的公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"06681":"脑动极光-B"},"translate_title":"Naodong Aurora Medical Technology's Hong Kong listing raises HK $583 million, leading the market in digital therapy for cognitive impairment","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06681":0.9},"content_text":"观点网讯：1月9日，浙江绍兴的脑动极光医疗科技有限公司（BrainAurora Medical Technology Limited，简称“脑动极光”）（06681.HK）在香港联合交易所主板成功上市。此次IPO全球发售1.81112亿股，占发行后总股份的14.30%，每股定价3.22港元，募集资金总额约5.83亿港元，净额约5.01亿港元。公开发售部分获得11.39倍认购，国际发售部分获得1.01倍认购。脑动极光此次IPO引入4名基石投资者，合计认购1.16406亿股，约合4850万美元。其中，天士力（600535.SH）通过天士力香港认购500万美元，天士力国际认购1000万美元，黄光伟先生认购400万美元，苏州策源认购2950万美元。基石投资者合计认购64.27%的发售股份，占发行后总股份的9.19%。脑动极光成立于2012年，是中国认知障碍数字疗法市场的资深参与者，也是中国首家将脑科学与人工智能技术相结合开发医疗级数字疗法产品的公司。公司产品管线涵盖由血管疾病、神经退行性疾病、精神疾病、儿童发育缺陷等诱发的广泛认知障碍的测评和干预。截至2024年10月22日，脑动极光的核心产品“脑功能信息管理平台软件系统”是中国首款获得监管批准的认知障碍数字疗法产品，已就四种主要类型认知障碍的八种适应症实现商业化，并正在开发其他几种认知障碍适应症。该产品已纳入中国30个省份的省级医保报销目录。免表声明：本文内容与数据由观点根据公开信息整理，不构成投资建议，使用前请核实。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2502403830"}

脑动极光医疗科技香港上市 募资5.83亿港元 认知障碍数字疗法市场领先

精彩评论

脑动极光医疗科技香港上市募资5.83亿港元认知障碍数字疗法市场领先